bibliographicCitation |
Ritchie M, Witbracht M, Nuño MM, Hoang D, Gillen DL, Grill JD. Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials. J Alzheimers Dis. 2022;90(3):1291–300. doi: 10.3233/jad-220801. PMID: 36245381. |